TrialBritish journal of cancer2015

Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.

T F Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.